5-Amino-1MQ is one of the compounds that has drawn attention in metabolism and longevity research over the past few years. It is not a peptide and not a GLP-1 agonist, but a small-molecule inhibitor of the NNMT enzyme. Let's break down what that means, why there is so much interest around it and how to choose it for research.

What 5-Amino-1MQ is and how it works

5-Amino-1MQ (5-amino-1-methylquinolinium) is an inhibitor of the NNMT (nicotinamide N-methyltransferase) enzyme. To follow the logic, you need one link:

  • NNMT "spends" nicotinamide, one of the molecules a cell uses to build NAD⁺.
  • When NNMT is too active (particularly in fat tissue), it pulls nicotinamide aside, and the NAD⁺ pool suffers.
  • By inhibiting NNMT, 5-Amino-1MQ theoretically preserves nicotinamide for NAD⁺ synthesis and affects the metabolism of adipocytes (fat cells).

That is why it is studied in the context of fat-tissue metabolism, energy exchange and maintaining NAD⁺ levels. One honest caveat: the evidence base is still mostly preclinical (cells and animals), so this is a subject of active research, not a finished therapy.

Form and research status

5-Amino-1MQ is a small molecule, usually given orally in research. Unlike peptides, it does not require injection. This is a research compound: no medical indications or "for yourself" regimens, dosages and protocols belong to controlled studies.

How to choose it for research

The criteria are the same as for any quality substance: an independent COA (Certificate of Analysis, a per-batch lab certificate) for the batch, purity by HPLC (high-performance liquid chromatography, a purity-testing method), correct storage and transparent origin. Longeva supplies 5-Amino-1MQ as a research substance with a COA, a reagent for laboratory metabolism research. See the specifications on the product page, and the molecule breakdown in the monograph.

Bottom line. 5-Amino-1MQ is a small-molecule NNMT inhibitor studied for its ability to preserve the NAD⁺ pool and affect fat-tissue metabolism. It is a research compound with a mostly preclinical evidence base, so the priorities when choosing are COA, HPLC purity and an honest research frame.